Advance Search
CHEN Shijun, ZHANG Xiaoyan, LUO Tian, WANG Kai. Effects of cyclophosphamide combined with prednisone on immune function, serum rheumatoid factors, C reaction protein and interleukin-17 in patients with lupus nephritis[J]. Journal of Clinical Medicine in Practice, 2019, 23(15): 75-78,82. DOI: 10.7619/jcmp.201915020
Citation: CHEN Shijun, ZHANG Xiaoyan, LUO Tian, WANG Kai. Effects of cyclophosphamide combined with prednisone on immune function, serum rheumatoid factors, C reaction protein and interleukin-17 in patients with lupus nephritis[J]. Journal of Clinical Medicine in Practice, 2019, 23(15): 75-78,82. DOI: 10.7619/jcmp.201915020
shu

Effects of cyclophosphamide combined with prednisone on immune function, serum rheumatoid factors, C reaction protein and interleukin-17 in patients with lupus nephritis

  • Ankang Central Hospital, Ankang, Shaanxi, 725000

More Information
  • Received Date: May 14, 2019
  • Revised Date: June 26, 2019
  • Available Online: February 23, 2021
  • Published Date: August 14, 2019
    Graphical Abstract
    • Abstract
  •   Objective  To investigate the effects of cyclophosphamide combined with prednisone on immune function, serum rheumatoid factor (RHF), C reactive protein (CRP) and interleukin-17 (IL-17) in patients with lupus nephritis (LN).
      Methods  Totally 90 patients with LN were randomly divided into control group and observation group, with 45 cases in each group. The control group was treated with prednisone, and the observation group was treated with cyclophosphamide on the basis of control group. The efficiency was compared between the two groups. The changes of immune function [immunoglobulin A (IgA), immunoglobulin G (IgG), immunoglobulin M (IgM), complement C3, complement C4], renal function [erythrocyte sedimentation rate (ESR), serum creatinine (Scr), 24-hour urinary protein quantification]and inflammatory factors (RHF, CRP and IL-17) before and after treatment were compared between the two groups. The incidence rate of adverse reactions was compared between the two groups.
      Results  The total effective rate of the observation group was significantly higher than that of the control group (P < 0.05). After treatment, levels of IgA, IgM, IgG, ESR, Scr, 24-hour urinary protein quantification, RHF, CRP, IL-17 decreased significantly, and levels of C3 and C4 increased significantly in two groups (P < 0.05). At the end of treatment, IgA, IgM, IgG, ESR, Scr, 24-hour urinary protein quantification, RHF, CRP, IL-17 in the observation group were significantly lower than those in the control group, while C3 and C4 were significantly higher than those in the control group (P < 0.05). There was no significant difference in the incidence rate of adverse reactions between the two groups (P>0.05).
      Conclusion  Cyclophosphamide combined with prednisone is effective and safe in treatment of LN, which can improve the immune function and renal function of patients, and reduce the levels of RHF, CRP and IL-17.
    • FullText(HTML)
    • References (22)
  • [1]
    方和敬, 李霜青, 应俊, 等. 黄芪生地辅助环磷酰胺-激素疗法对狼疮性肾炎感染患者炎症状态的影响研究[J]. 中华医院感染学杂志, 2016, 26(19): 4389-4391. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY201619022.htm
    [2]
    何勇, 刘德慧, 吴荣艳, 等. 他克莫司与环磷酰胺诱导治疗狼疮性肾炎的临床疗效及安全性[J]. 中国老年学杂志, 2016, 36(22): 5697-5698. doi: 10.3969/j.issn.1005-9202.2016.22.094
    [3]
    秦登优, 伍正彬, 田恩, 等. 他克莫司联合环磷酰胺和糖皮质激素治疗狼疮性肾炎的疗效观察[J]. 医学研究杂志, 2018, 47(7): 141-144. https://www.cnki.com.cn/Article/CJFDTOTAL-YXYZ201807035.htm
    [4]
    Momtaz M, Fayed A, Wadie M, et al. Retrospective analysis of nephritis response and renal outcome in a cohort of 928 Egyptian lupus nephritis patients: a university hospital experience[J]. Lupus, 2017, 26(14): 1564-1570. doi: 10.1177/0961203317716320
    [5]
    陈灏珠. 实用内科学[M]. 13版. 北京: 北京人民出版社, 2009: 1486-1488.
    [6]
    刘琪, 罗香雅, 陈瑞林, 等. 霉酚酸酯联合环磷酰胺与环磷酰胺单药诱导治疗狼疮性肾炎的效果对比[J]. 广东医学, 2017, 38(14): 2212-2216. doi: 10.3969/j.issn.1001-9448.2017.14.031
    [7]
    Jabrane M, Lahcen Z A, Fadili W, et al. A case of PRES in an active lupus nephritis patient after treatment of corticosteroid and cyclophosphamide[J]. Rheumatology International, 2015, 35(5): 935-938. doi: 10.1007/s00296-014-3173-1
    [8]
    黄山, 林佳静. 吗替麦考酚酯与环磷酰胺联合激素治疗狼疮性肾炎的疗效对比分析[J]. 解放军预防医学杂志, 2018, 36(2): 217-219, 243. https://www.cnki.com.cn/Article/CJFDTOTAL-JYYX201802018.htm
    [9]
    Moroni G, Raffiotta F, Trezzi B, et al. Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study[J]. Rheumatology, 2014, 53(9): 1570-1577. doi: 10.1093/rheumatology/ket462
    [10]
    Sakai R, Kurasawa T, Nishi E, et al. Efficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in Japan[J]. Lupus, 2018, 27(2): 273-282. doi: 10.1177/0961203317719148
    [11]
    刘力, 胡坚, 鲁卓林, 等. 环磷酰胺治疗儿童狼疮性肾炎药物代谢的临床研究[J]. 中华实用儿科临床杂志, 2017, 32(21): 1644-1648. doi: 10.3760/cma.j.issn.2095-428X.2017.21.011
    [12]
    Wallace D J, Goldfinger D, Pepkowitz S H, et al. Randomized controlled trial of pulse/synchronization cyclophosphamide/apheresis for proliferative lupus nephritis[J]. J Clin Apheresis, 1998, 13(4): 163-166. doi: 10.1002/(SICI)1098-1101(1998)13:4<163::AID-JCA4>3.0.CO;2-1
    [13]
    吴雪莲, 叶忠伟, 毛小媛, 等. 糖皮质激素+环磷酰胺+他克莫司联合治疗Ⅲ+Ⅴ、Ⅳ+Ⅴ型狼疮性肾炎的临床研究[J]. 中国生化药物杂志, 2017, 37(1): 188-190. https://www.ixueshu.com/document/e4859208ffe87b81d886dc0eb60318d2318947a18e7f9386.html
    [14]
    Ciruelo E, Cruz J D L, Ignacio López M D, et al. Cumulative rate of relapse of lupus nephritis after successful treatment with cyclophosphamide[J]. Arthritis & Rheumatology, 2014, 39(12): 2028-2034. doi: 10.1002/art.1780391212/full
    [15]
    王先惠, 熊瑛, 谢亚萍, 等. 环磷酰胺治疗狼疮性肾炎患者临床疗效及对血清胱抑素C、同型半胱氨酸和趋化因子配体16的影响[J]. 疑难病杂志, 2016, 15(2): 158-160, 164. doi: 10.3969/j.issn.1671-6450.2016.02.013
    [16]
    Wang Y, Yu F, Song D, et al. Podocyte involvement in lupus nephritis based on the 2003 ISN/RPS system: a large cohort study from a single centre[J]. Rheumatology, 2014, 53(7): 1235-1244. doi: 10.1093/rheumatology/ket491
    [17]
    雷友富. 环磷酰胺联合泼尼松对狼疮性肾炎患者肾功能改善及生活质量的影响[J]. 北方药学, 2017, 14(9): 44-45. doi: 10.3969/j.issn.1672-8351.2017.09.039
    [18]
    张培敏, 樊蓉, 李想, 等. 泼尼松联合霉酚酸酯对比环磷酰胺治疗狼疮性肾炎的系统评价[J]. 实用药物与临床, 2015, 18(2): 130-135. https://www.cnki.com.cn/Article/CJFDTOTAL-LYLC201502003.htm
    [19]
    邓菲, 丁涵露, 冯静, 等. 来氟米特联合泼尼松对增殖型狼疮性肾炎诱导期治疗效果的临床研究[J]. 海南医学, 2017, 28(4): 544-547. doi: 10.3969/j.issn.1003-6350.2017.04.008
    [20]
    陈菊, 周君, 朱永俊, 等. 他克莫司与环磷酰胺治疗更年期狼疮性肾炎的效果及安全性比较[J]. 解放军医药杂志, 2017, 29(8): 90-92. doi: 10.3969/j.issn.2095-140X.2017.08.024
    [21]
    Houssiau, Frédéric A, Vasconcelos C, et al. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: Lessons from long-term follow up of patients in the Euro-Lupus Nephritis Trial[J]. Arthritis & Rheumatology, 2014, 50(12): 3934-3940. http://www.ncbi.nlm.nih.gov/pubmed/15593207
    [22]
    刘美兰, 马福哲, 吴昊, 等. 狼疮性肾炎患者血清IL-18、IL-34水平及其意义[J]. 中国现代医学杂志, 2018, 28(2): 53-56. doi: 10.3969/j.issn.1005-8982.2018.02.010
    • Related Articles

  • Related Articles

    [1]FENG Yalin, ZHOU Yuanting, ZOU Wenjun. Research progress on mental intervention in patients with diabetic retinopathy[J]. Journal of Clinical Medicine in Practice, 2025, 29(4): 134-138, 148. DOI: 10.7619/jcmp.20242834
    [2]GONG Yujia, LI Hailong, CAO Hui. Mechanism of circ-001209 on retinal angiogenesis in rats with diabetic retinopathy by regulating interleukin-33/suppression of tumorigenicity 2 signaling pathway[J]. Journal of Clinical Medicine in Practice, 2025, 29(4): 23-18, 33. DOI: 10.7619/jcmp.20243144
    [3]HE Jiaqin, WU Hongyan, CAI Qian, LU Yu, LIU Xinliang. Values of serum triglyceride-glucose index combined with retinol-binding protein and β2-microglobulin in prediction and screening of diabetic retinopathy[J]. Journal of Clinical Medicine in Practice, 2023, 27(18): 70-74. DOI: 10.7619/jcmp.20231267
    [4]WU Huihui, ZHANG Xue, WANG Yan, LIU Yan, LUO Na, CHEN Fang. Quantitative study of optic disc blood flow density and thickness of peripapillary retinal nerve fiber layer in patients with diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2022, 26(7): 57-61. DOI: 10.7619/jcmp.20213748
    [5]HAN Zhongshu, YU Jinqiang. Treatment advances of macular edema caused by retinal vein occlusion[J]. Journal of Clinical Medicine in Practice, 2020, 24(16): 122-128. DOI: 10.7619/jcmp.202016035
    [6]PENG Jingying, ZHANG Junjun, JIANG Xiaoshuang, LI Ruifeng, LI Ling. Correlation between cilioretinal artery and central visual impairment in patients with central retinal artery occlusion[J]. Journal of Clinical Medicine in Practice, 2017, (7): 102-104. DOI: 10.7619/jcmp.201707028
    [7]DAI Shuxiang, WANG Guangmei, HUANG Delian, TIAN Mei. Observation and nursing of diabetic retinopathy treated with traditional Chinese medicine in combination with whole retina photocoagulation[J]. Journal of Clinical Medicine in Practice, 2017, (6): 49-51. DOI: 10.7619/jcmp.201706015
    [8]LI Yunxi, YANG Yongli, LI Xiaxuan. Clinical efficacy of integrative therapy in the treatment of diabetic retinopathy[J]. Journal of Clinical Medicine in Practice, 2013, (15): 103-104,107. DOI: 10.7619/jcmp.201315038
    [9]LU Ai-rong. Dynamic monitoring of patients with diabetic retinal detachment under local anesthesia its nursing intervention[J]. Journal of Clinical Medicine in Practice, 2012, (6): 78-80. DOI: 10.3969/j.issn.1672-2353.2012.06.031
    [10]ZHAO Min, BU Ping. Study on the anterior uveitis after tripie combined surgery for the experimental rabbits glaucoma[J]. Journal of Clinical Medicine in Practice, 2011, (9): 12-16. DOI: 10.3969/j.issn.1672-2353.2011.09.004

  • Cited by

    Periodical cited type(1)

    1. 赵阳，董雪. PICC洗澡防水长袖手套的设计和说明. 当代护士(中旬刊). 2021(08): 190-191 .

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML
    Article views PDF downloads Cited by(1)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return